BackSynovics Pharmaceuticals Overview

Synovics Pharmaceuticals Common Stock

Track Synovics Pharmaceuticals's common stock ($40K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$39654.00
↓ 2.23% YoYΔ $-906.00 vs prior year quarter

Peer trimmed avg / median

Loading

Synovics Pharmaceuticals Common Stock History

Loading

Synovics Pharmaceuticals vs. peers: Common Stock Comparison

Loading

Synovics Pharmaceuticals Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Synovics Pharmaceuticals (SYVC) FAQ

The latest common stock for SYVC is $40K as of July 2009. That compares with $41K in the prior-year period — down 2.2% year over year. Investors often review this figure alongside Synovics Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, SYVC's common stock moved from $41K to $40K — a 2.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Synovics Pharmaceuticals's operating scale or balance-sheet position.

A common stock figure of $40K for SYVC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SYVC's common stock ($40K), review year-over-year change from $41K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Synovics Pharmaceuticals's common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.